Cancer-associated synonymous mutations reveal stress signal-dependent mRNA folding that selectively modulates protein function.

View at publisher
Authors: Sivakumar Vadivel Gnanasundram, Lixiao Wang, Sa Chen, Ondřej Bonczek, Bořivoj Vojtěšek, Robin Fåhræus
Cited by: 1

Abstract

Recent technical advances have facilitated studies on changes in mRNA structures in response to signaling pathways. However, if mRNA structures can affect the function of the encoded protein remains poorly understood. In-cell RNA structural probing (SHAPE-MaP) demonstrates how two cancer-associated synonymous mutations (CASMs) at proline codon 34 (c.102 C>A and c.102 C>G) prevent DNA damage-induced TP53 mRNA folding, whereas the non-cancer-associated c.102 C>U mutation does not. Transcript and chromatin immunoprecipitation (ChIP) analysis reveal that p53 expressed from CASM34 has reduced promoter binding and reduced induction of p53 downstream target genes PUMA and 14-3-3-σ, but not p21CDKN1A. Transcriptome analysis reveals a CASM34-mediated global attenuation of DNA damage–responsive gene expression. Together, the results demonstrate that CASM34 interferes with signal-induced p53 mRNA folding during DNA damage, leading to selective modulation of p53 protein activity. More broadly, our findings highlight a general concept by which cancer-associated synonymous mutations target signal-induced mRNA structures that influence the encoded protein.

Fields of Study & Subjects

14-3-3 protein interactions RNA Research and Splicing Cancer-related gene regulation

Publication details

Journal / source
RNA
Publisher
Cold Spring Harbor Laboratory
Volume
32
Issue
7
Pages
rna.080976.126–rna.080976.126
Publication date
17 April 2026
Language
EN